Literature DB >> 28980180

Non-Inferiority Trials in Medicine: Practice Changing or a Self-Fulfilling Prophecy?

Vinay Prasad1,2,3.   

Abstract

Year:  2018        PMID: 28980180      PMCID: PMC5756169          DOI: 10.1007/s11606-017-4191-y

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  8 in total

Review 1.  Publication of noninferiority clinical trials: changes over a 20-year interval.

Authors:  Katie J Suda; Anne M Hurley; Trevor McKibbin; Susannah E Motl Moroney
Journal:  Pharmacotherapy       Date:  2011-09       Impact factor: 4.705

Review 2.  Head-to-head randomized trials are mostly industry sponsored and almost always favor the industry sponsor.

Authors:  Maria Elena Flacco; Lamberto Manzoli; Stefania Boccia; Lorenzo Capasso; Katina Aleksovska; Annalisa Rosso; Giacomo Scaioli; Corrado De Vito; Roberta Siliquini; Paolo Villari; John P A Ioannidis
Journal:  J Clin Epidemiol       Date:  2015-02-07       Impact factor: 6.437

3.  Informed Consent to Study Purpose in Randomized Clinical Trials of Antibiotics, 1991 Through 2011.

Authors:  Peter Doshi; Peter Hur; Mark Jones; Husam Albarmawi; Tom Jefferson; Daniel J Morgan; Patricia A Spears; John H Powers
Journal:  JAMA Intern Med       Date:  2017-10-01       Impact factor: 21.873

4.  Pazopanib versus sunitinib in metastatic renal-cell carcinoma.

Authors:  Robert J Motzer; Thomas E Hutson; David Cella; James Reeves; Robert Hawkins; Jun Guo; Paul Nathan; Michael Staehler; Paul de Souza; Jaime R Merchan; Ekaterini Boleti; Kate Fife; Jie Jin; Robert Jones; Hirotsugu Uemura; Ugo De Giorgi; Ulrika Harmenberg; Jinwan Wang; Cora N Sternberg; Keith Deen; Lauren McCann; Michelle D Hackshaw; Rocco Crescenzo; Lini N Pandite; Toni K Choueiri
Journal:  N Engl J Med       Date:  2013-08-22       Impact factor: 91.245

5.  Medical research: Trial unpredictability yields predictable therapy gains.

Authors:  Benjamin Djulbegovic; Ambuj Kumar; Paul Glasziou; Branko Miladinovic; Iain Chalmers
Journal:  Nature       Date:  2013-08-22       Impact factor: 49.962

6.  Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement.

Authors:  Gilda Piaggio; Diana R Elbourne; Stuart J Pocock; Stephen J W Evans; Douglas G Altman
Journal:  JAMA       Date:  2012-12-26       Impact factor: 56.272

Review 7.  Non-inferiority trials: are they inferior? A systematic review of reporting in major medical journals.

Authors:  Sunita Rehal; Tim P Morris; Katherine Fielding; James R Carpenter; Patrick P J Phillips
Journal:  BMJ Open       Date:  2016-10-07       Impact factor: 2.692

Review 8.  Empirical Consequences of Current Recommendations for the Design and Interpretation of Noninferiority Trials.

Authors:  Scott K Aberegg; Andrew M Hersh; Matthew H Samore
Journal:  J Gen Intern Med       Date:  2017-09-05       Impact factor: 5.128

  8 in total
  1 in total

1.  Value Assessment and Quantitative Benefit-Risk Modelling of Biosimilar Infliximab for Crohn's Disease.

Authors:  Heather Catt; Keith Bodger; Jamie J Kirkham; Dyfrig A Hughes
Journal:  Pharmacoeconomics       Date:  2019-12       Impact factor: 4.981

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.